Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Role of IL-1 receptors in osteoporosis elucidated

Sep. 17, 1997

Highlights from the Japanese Society of Bone Metabolism Research

Sep. 17, 1997

Fenfluramine, dexfenfluramine voluntarily withdrawn

Sep. 16, 1997

Hormone therapy vs. simvastatin for hypercholesterolemia in postmenopausal women

Sep. 15, 1997

Novartis evaluates SDZ-267-489 and analogues for increasing HDL cholesterol

Sep. 15, 1997

Potent GH secretagogues synthesized at Merck & Co.

Sep. 15, 1997

Kirin's TPO enters phase II in several Asian countries

Sep. 15, 1997

Cannabinoid receptor ligand shows synergistic hematopoietic effects in vitro

Sep. 12, 1997

Kampo medicine with hypolipidemic and antiatherosclerotic effects

Sep. 12, 1997

Focus on diabetes research in the U.S.

Sep. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...